Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemiaS Amadori, W Arcese, G Isacchi, et al.
Blood|April 1, 1987
Increased susceptibility of peripheral mononuclear cells of leukemic patients to HTLV-I infection in vitroG Graziani, D Pasqualetti, M Lopez, et al.
Endocrinologia Experimentalis|March 1, 1990
Effects of cholinergic muscarinic antagonist pirenzepine on GH response to GHRH 1-40 in patients with anorexia nervosaM Rolla, A Andreoni, D Belliti, et al.
Leukemia|August 19, 2005
Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocolsA Pession, R Rondelli, G Basso, et al.
American Journal of Hematology|August 6, 1998
Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignanciesG D'Arena, P Musto, L Di Mauro, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Biochemical interactions between methotrexate and 1-beta-D-arabinofuranosylcytosine in hematopoietic cells of children: a Pediatric Oncology Group studyE M Newman, D G Villacorte, A M Testi, et al.
Blood|April 15, 1991
Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemiaF Lo Coco, G Avvisati, D Diverio, et al.
Leukemia|September 27, 2003
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent diseaseF Lo-Coco, A Romano, A Mengarelli, et al.
Transplantation Proceedings|December 20, 2007
Non-Hodgkin's lymphoma, presenting as an isolated endobronchial mass after bilateral lung transplantation: a case reportT De Giacomo, F Venuta, M Anile, et al.
Leukemia & Lymphoma|June 28, 2001
Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center studyA M Carella, N Cascavilla, M M Greco, et al.
Pageof 14